Publications by authors named "H T Langston"

Chagas disease is a zoonosis caused by the protozoan parasite Trypanosoma cruzi. Clinical outcomes range from long-term asymptomatic carriage to cardiac, digestive, neurological and composite presentations that can be fatal in both acute and chronic stages of the disease. Studies of T.

View Article and Find Full Text PDF

Chagas disease is caused by Trypanosoma cruzi, a protozoan parasite that displays considerable genetic diversity. Infections result in a range of pathological outcomes, and different strains can exhibit a wide spectrum of anti-parasitic drug tolerance. The genetic determinants of infectivity, virulence and therapeutic susceptibility remain largely unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Digestive Chagas disease (DCD) is caused by Trypanosoma cruzi infection, and the study aims to explore its pathology and treatment options using a mouse model.
  • Treatment with the anti-parasitic drug benznidazole can lead to recovery in gastrointestinal function if administered early, but delayed treatment results in relapsed symptoms and permanent tissue damage.
  • The research emphasizes the importance of early diagnosis and treatment of T. cruzi infection to prevent DCD, suggesting that even asymptomatic individuals could benefit from treatment with benznidazole.
View Article and Find Full Text PDF

Chronic Chagas cardiomyopathy (CCC) results from infection with the protozoan parasite and is a prevalent cause of heart disease in endemic countries. We previously found that cardiac fibrosis can vary widely in C3H/HeN mice chronically infected with JR strain, mirroring the spectrum of heart disease in humans. In this study, we examined functional cardiac abnormalities in this host:parasite combination to determine its potential as an experimental model for CCC.

View Article and Find Full Text PDF

Digestive Chagas disease (DCD) is an enteric neuropathy caused by Trypanosoma cruzi infection. The mechanism of pathogenesis is poorly understood and the lack of a robust, predictive animal model has held back research. We screened a series of mouse models using gastrointestinal tracer assays and in vivo infection imaging systems to discover a subset exhibiting chronic digestive transit dysfunction and significant retention of faeces in both sated and fasted conditions.

View Article and Find Full Text PDF